Vanda Pharmaceuticals Stock Investor Sentiment
| VNDA Stock | USD 5.19 0.21 4.22% |
About 58% of all Vanda Pharmaceuticals' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Vanda Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Vanda Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Vanda Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Vanda |
Vanda Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Vanda Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Vanda Pharmaceuticals that are available to investors today. That information is available publicly through Vanda media outlets and privately through word of mouth or via Vanda internal channels. However, regardless of the origin, that massive amount of Vanda data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vanda Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vanda Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vanda Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vanda Pharmaceuticals alpha.
Vanda Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Novo sinks on obesity drug results Sanofi reveals anticipated MS data | 09/20/2024 |
2 | Acquisition by Gunther Birznieks of 32700 shares of Vanda Pharmaceuticals subject to Rule 16b-3 | 10/04/2024 |
3 | Cycle Pharma Is Said to Stand By 488 Million Offer for Vanda | 10/14/2024 |
4 | Biotech Stock Roundup VNDA, JAZZ Up on Updates, NVAX Suffers Setback More | 10/17/2024 |
5 | Vanda started at buy by H.C. Wainwright, negative enterprise value cited | 10/31/2024 |
6 | What is HC Wainwrights Forecast for VNDA FY2024 Earnings | 11/01/2024 |
7 | Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results | 11/06/2024 |
8 | Vanda Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Revenue Surge Amidst Rising ... | 11/07/2024 |
9 | Disposition of 5000 shares by Mitchell Stephen Ray of Vanda Pharmaceuticals at 5.1726 subject to Rule 16b-3 | 11/14/2024 |
10 | Stephen Ray Mitchell Sells 5,000 Shares of Vanda Pharmaceuticals Inc. Stock | 11/20/2024 |
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |